Targeted Molecular Imaging in Adrenal Disease—An Emerging Role for Metomidate PET-CT

Adrenal lesions present a significant diagnostic burden for both radiologists and endocrinologists, especially with the increasing number of adrenal ‘incidentalomas’ detected on modern computed tomography (CT) or magnetic resonance imaging (MRI). A key objective is the reliable distinction of benign disease from either primary adrenal malignancy (e.g., adrenocortical carcinoma or malignant forms of pheochromocytoma/paraganglioma (PPGL)) or metastases (e.g., bronchial, renal). Benign lesions may still be associated with adverse sequelae through autonomous hormone hypersecretion (e.g., primary aldosteronism, Cushing’s syndrome, phaeochromocytoma). Here, identifying a causative lesion, or lateralising the disease to a single adrenal gland, is key to effective management, as unilateral adrenalectomy may offer the potential for curing conditions that are typically associated with significant excess morbidity and mortality. This review considers the evolving role of positron emission tomography (PET) imaging in addressing the limitations of traditional cross-sectional imaging and adjunctive techniques, such as venous sampling, in the management of adrenal disorders. We review the development of targeted molecular imaging to the adrenocortical enzymes CYP11B1 and CYP11B2 with different radiolabeled metomidate compounds. Particular consideration is given to iodo-metomidate PET tracers for the diagnosis and management of adrenocortical carcinoma, and the increasingly recognized utility of 11C-metomidate PET-CT in primary aldosteronism.

• Publication year

  2016

• Venue

  Diagnostics

• Publication date

  2016-11-18

• Fields of study

  Medicine

• Identifiers
  DOI 10.3390/diagnostics6040042PMID 27869719PMCID 5192517
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• A Novel CYP11B2-Specific Imaging Agent for Detection of Unilateral Subtypes of Primary Aldosteronism.

  2016cited by this paper
• Adrenal Incidentalomas: Clinical Controversies and Modified Recommendations.

  2016cited by this paper
• The Management of Primary Aldosteronism: Case Detection, Diagnosis, and Treatment: An Endocrine Society Clinical Practice Guideline.

  2016influential reference
• Adrenal vein sampling versus CT scan to determine treatment in primary aldosteronism: an outcome-based randomised diagnostic trial.

  2016cited by this paper
• A case of adrenal Cushing’s syndrome with bilateral adrenal masses

  2016cited by this paper
• Management of adrenal incidentalomas: European Society of Endocrinology Clinical Practice Guideline in collaboration with the European Network for the Study of Adrenal Tumors.

  2016cited by this paper
• Adrenal surgery in England: better outcomes in high‐volume practices

  2016cited by this paper
• Hormonal, Radiological, NP-59 Scintigraphy, and Pathological Correlations in Patients With Cushing's Syndrome Due to Primary Pigmented Nodular Adrenocortical Disease (PPNAD).

  2015cited by this paper
• Nuclear imaging in the diagnosis of primary aldosteronism

  2015cited by this paper
• Prognostic value of semiquantification NP-59 SPECT/CT in primary aldosteronism patients after adrenalectomy

  2014cited by this paper
• Radiosynthesis of [124I]Iodometomidate and Biological Evaluation Using Small-Animal PET

  2014cited by this paper
• Diagnosing unilateral primary aldosteronism – comparison of a clinical prediction score, computed tomography and adrenal venous sampling

  2014cited by this paper
• Functional characterization of adrenal lesions using [123I]IMTO-SPECT/CT.

  2013cited by this paper
• [123I]Iodometomidate imaging in adrenocortical carcinoma

  2013cited by this paper
• Virilization of a Young Girl Caused by Concomitant Ectopic and Intra-Adrenal Adenomas of the Adrenal Cortex

  2013cited by this paper
• [¹²³I]Iodometomidate imaging in adrenocortical carcinoma.

  2013cited by this paper
• Evaluation of the sensitivity and specificity of (11)C-metomidate positron emission tomography (PET)-CT for lateralizing aldosterone secretion by Conn's adenomas.

  2012cited by this paper
• Etomidate in the emergency management of hypercortisolemia.

  2012cited by this paper
• [131I]iodometomidate for targeted radionuclide therapy of advanced adrenocortical carcinoma.

  2012cited by this paper
• Evaluation of the Sensitivity and Specificity of 11C-Metomidate Positron Emission Tomography (PET)-CT for Lateralizing Aldosterone Secretion by Conn's Adenomas

  2012cited by this paper
• A clinical prediction score to diagnose unilateral primary aldosteronism.

  2012cited by this paper
• An unusual presentation of Carney complex with diffuse primary pigmented nodular adrenocortical disease on one adrenal gland and a nonpigmented adrenocortical adenoma and focal primary pigmented nodular adrenocortical disease on the other.

  2012cited by this paper
• Adrenal imaging: a comprehensive review.

  2012cited by this paper
• A comprehensive review of the clinical aspects of primary aldosteronism

  2011cited by this paper
• Incidentally discovered adrenal mass.

  2011cited by this paper
• Adrenal Venous Sampling: Evaluation of the German Conn's Registry

  2011cited by this paper
• Impact of Different Diagnostic Criteria During Adrenal Vein Sampling on Reproducibility of Subtype Diagnosis in Patients With Primary Aldosteronism

  2010cited by this paper
• Incidental adrenal lesions: accuracy of characterization with contrast-enhanced washout multidetector CT--10-minute delayed imaging protocol revisited in a large patient cohort.

  2010cited by this paper
• 11C-metomidate positron emission tomography after dexamethasone suppression for detection of small adrenocortical adenomas in primary aldosteronism

  2010cited by this paper
• Adrenal imaging: why, when, what, and how? Part 1. Why and when to image?

  2010influential reference
• Adrenal Cortical Imaging With I-131 NP-59 SPECT-CT

  2010cited by this paper
• Adrenal mass imaging with multidetector CT: pathologic conditions, pearls, and pitfalls.

  2009cited by this paper
• Masked volume wise principal component analysis of small adrenocortical tumours in dynamic [11C]-metomidate positron emission tomography

  2009influential reference
• (18)F-labelled metomidate analogues as adrenocortical imaging agents.

  2009cited by this paper
• Computed tomography, magnetic resonance imaging and 11C-metomidate positron emission tomography for evaluation of adrenal incidentalomas.

  2009cited by this paper
• Adrenal imaging with multidetector CT: evidence-based protocol optimization and interpretative practice.

  2009cited by this paper
• Adrenal imaging with MDCT: Nonneoplastic disease.

  2009cited by this paper
• Incidental adrenal lesions: principles, techniques, and algorithms for imaging characterization.

  2008influential reference
• [123 I]Iodometomidate for molecular imaging of adrenocortical cytochrome P450 family 11B enzymes.

  2008influential reference
• Case detection, diagnosis, and treatment of patients with primary aldosteronism: an endocrine society clinical practice guideline.

  2008cited by this paper
• Imaging techniques for adrenal lesion characterization.

  2008cited by this paper
• The Role of Adrenal Scintigraphy in the Preoperative Management of Primary Aldosteronism

  2008cited by this paper
• Distinguishing benign from malignant adrenal masses: multi-detector row CT protocol with 10-minute delay.

  2006cited by this paper
• [11C]metomidate positron emission tomography of adrenocortical tumors in correlation with histopathological findings.

  2006cited by this paper
• Adrenal venous sampling in primary hyperaldosteronism: comparison of radiographic with biochemical success and the clinical decision-making with "less than ideal" testing.

  2006cited by this paper
• [18F]FETO: metabolic considerations

  2006cited by this paper
• [18F]FETO for adrenocortical PET imaging: a pilot study in healthy volunteers

  2006cited by this paper
• A new application of pre-normalized principal component analysis for improvement of image quality and clinical diagnosis in human brain PET studies - Clinical brain studies using [11C]-GR205171, [11C]-l-deuterium-deprenyl, [11C]-5-Hydroxy-l-Tryptophan, [11C]-l-DOPA and Pittsburgh Compound-B

  2006cited by this paper
• Younger Adults' Understanding of Questions for a Service User Experience Survey. Funded/commissioned by: The Health and Social Care Information Centre

  2006cited by this paper
• Adrenocortical carcinoma

  2006cited by this paper
• Evidence for an increased rate of cardiovascular events in patients with primary aldosteronism.

  2005cited by this paper
• [123/131I]Iodometomidate as a radioligand for functional diagnosis of adrenal disease: synthesis, structural requirements and biodistribution

  2004cited by this paper
• Imaging of adrenal incidentalomas with PET using (11)C-metomidate and (18)F-FDG.

  2004cited by this paper
• Positron emission tomography imaging of adrenal masses: 18F-fluorodeoxyglucose and the 11β-hydroxylase tracer 11C-metomidate

  2004cited by this paper
• Clinical experience with the adrenal scanning agents iodine 131-19-iodocholesterol and selenium 75-6-selenomethylcholesterol

  2004cited by this paper
• The clinically inapparent adrenal mass: update in diagnosis and management.

  2004cited by this paper
• Uptake of75Se-selenocholesterol by an adrenal cortical carcinoma and its metastases

  2004cited by this paper
• Comparison of three different purification methods for the routine preparation of [11C] Metomidate.

  2003cited by this paper
• Management of the Clinically Inapparent Adrenal Mass (Incidentaloma)

  2003cited by this paper
• 11C-metomidate PET imaging of adrenocortical cancer

  2003influential reference
• Prevalence and natural history of adrenal incidentalomas.

  2003cited by this paper
• In vivo and in vitro evaluation of [18F]FETO with respect to the adrenocortical and GABAergic system in rats

  2003cited by this paper
• Synthesis of [18F]FETO, a novel potential 11‐β hydroxylase inhibitor

  2003cited by this paper
• Management of clinically inapparent adrenal mass.

  2002cited by this paper
• Functional scintigraphy of the adrenal gland.

  2002cited by this paper
• Hyperaldosteronism Among Black and White Subjects With Resistant Hypertension

  2002cited by this paper
• PET Imaging of Adrenal Cortical Tumors with the 11 ß-Hydroxylase Tracer 11 C-Metomidate

  2000cited by this paper
• Delayed enhanced CT of lipid-poor adrenal adenomas.

  2000cited by this paper
• PET imaging of adrenal cortical tumors with the 11beta-hydroxylase tracer 11C-metomidate.

  2000cited by this paper
• In vitro and in vivo primate evaluation of carbon-11-etomidate and carbon-11-metomidate as potential tracers for PET imaging of the adrenal cortex and its tumors.

  1998influential reference
• CT time-attenuation washout curves of adrenal adenomas and nonadenomas.

  1998cited by this paper
• Incidentally discovered adrenal masses.

  1997cited by this paper
• Metabolic and pharmacokinetic considerations in the design of 2-phenyl substituted metyrapone derivatives: 2-methoxyphenylmetyrapone as a radioligand for functional diagnosis of adrenal pathology.

  1995cited by this paper
• Different inhibitory effect of etomidate and ketoconazole on the human adrenal steroid biosynthesis

  1993cited by this paper
• Incidentally discovered adrenal masses.

  1989cited by this paper
• Inhibition of adrenal steroidogenesis by the anesthetic etomidate.

  1984cited by this paper
• The incidentally discovered adrenal mass.

  1983cited by this paper
• CLINICAL EXPERIENCE WITH 75Se SELENOMETHYLCHOLESTEROL ADRENAL IMAGING

  1981influential reference

• [Novel imaging techniques for the differential diagnosis of adrenal tumors, pheochromocytomas and paragangliomas].

  2026cites this paper
• Nuclear Imaging in the Assessment of Adrenal Tumors.

  2025cites this paper
• 68Ga-Pentixafor PET/CT for the assessment of therapeutic outcomes following superselective adrenal arterial embolization in patients with primary aldosteronism

  2025cites this paper
• A comparison of the performance of 68Ga-Pentixafor PET/CT versus adrenal vein sampling for subtype diagnosis in primary aldosteronism

  2024cites this paper
• Quantitative imaging biomarkers in the assessment of adrenal nodules

  2024cites this paper
• Automated radiosynthesis of [18 F]CETO, a PET radiotracer for imaging adrenal glands, on Synthra RNplus.

  2023cites this paper
• Key to the Treatment of Primary Aldosteronism in Secondary Hypertension: Subtype Diagnosis

  2023cites this paper
• 2023 Korean Endocrine Society Consensus Guidelines for the Diagnosis and Management of Primary Aldosteronism

  2023cites this paper
• Personalized molecular visualization and radiotheranostics of adrenal tumors

  2022cites this paper
• Endocrinología, Diabetes y Nutrición: resumen del año 2022

  2022cites this paper
• ACTH-Independent Cushing’s Syndrome Caused by an Ectopic Adrenocortical Adenoma in the Renal Hilum

  2022cites this paper
• Integration of molecular imaging in the personalized approach of patients with adrenal masses.

  2022cites this paper
• Large adrenal mass heralding the diagnosis of occult extra-adrenal malignancy in two patients

  2021cites this paper
• A multidisciplinary approach to the management of adrenal incidentaloma

  2021cites this paper
• [Adrenal imaging: anatomy and pathology (literature review)].

  2021cites this paper
• Imaging CXCR4 expression in patients with suspected primary hyperaldosteronism

  2020cites this paper
• Functional imaging of adrenal cortex.

  2020cites this paper
• Functional imaging studies of the adrenal cortex

  2020cites this paper
• High Prevalence of Adrenal Remnant Tissue in Patients Undergoing Bilateral Adrenalectomy for Cushing’s Disease

  2020cites this paper
• Practical guide on the initial evaluation, follow-up, and treatment of adrenal incidentalomas. Adrenal Diseases Group of the Spanish Society of Endocrinology and Nutrition

  2020cites this paper
• Practical guide on the initial evaluation, follow-up, and treatment of adrenal incidentalomas Adrenal Diseases Group of the Spanish Society of Endocrinology and Nutrition.

  2020cites this paper
• Adrenal cortical carcinoma: pathology, genomics, prognosis, imaging features, and mimics with impact on management

  2020cites this paper
• Development of [ 18 F]FAMTO: A novel fl uorine-18 labelled positron emission tomography (PET) radiotracer for imaging CYP11B1 and CYP11B2 enzymes in adrenal glands

  2019cites this paper
• Primary hyperaldosteronism—seek and you may find

  2019cites this paper
• Development of [ 18 F]FAMTO: A novel fl uorine-18 labelled positron emission tomography (PET) radiotracer for imaging CYP11B1 and CYP11B2 enzymes in adrenal glands

  2019cites this paper
• A Diagnostic Approach to Adrenocortical Tumors.

  2019cites this paper
• 11C‐Metomidate PET/CT is a useful adjunct for lateralization of primary aldosteronism in routine clinical practice

  2019cites this paper
• A simple and efficient automated cGMP-compliant radiosynthesis of [11 C]metomidate using solid phase extraction cartridge purification.

  2019cites this paper
• Development of [18F]FAMTO: A novel fluorine-18 labelled positron emission tomography (PET) radiotracer for imaging CYP11B1 and CYP11B2 enzymes in adrenal glands

  2019cites this paper
• FAMTO : a novel fluorine-18 labelled positron emission tomography ( PET ) radiotracer for imaging CYP 11 B 1 and CYP 11 B 2 enzymes in adrenal glands

  2018cites this paper
• Conn’s Syndrome

  2018cites this paper
• Accuracy of adrenal imaging and adrenal venous sampling in diagnosing unilateral primary aldosteronism

  2017cites this paper
• La sécrétion de cortisol constitue un piège dans la caractérisation des adénome corticosurrénaliens : étude clinicopathologique

  2017cites this paper
• PET Imaging for Endocrine Malignancies: From Woe to Go

  2017cites this paper
• Subtype Diagnosis of Primary Aldosteronism: Is Adrenal Vein Sampling Always Necessary?

  2017cites this paper
• Primärer Hyperaldosteronismus: Diagnostik und Therapie

  2017cites this paper
• Subtyping of Patients with Primary Aldosteronism: An Update

  2017cites this paper